SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-313125
Filing Date
2021-10-29
Accepted
2021-10-29 14:53:58
Documents
7
Period of Report
2021-10-29

Document Format Files

Seq Description Document Type Size
1 6-K d187488d6k.htm 6-K 10501
2 EX-99.1 d187488dex991.htm EX-99.1 10994
3 EX-99.2 d187488dex992.htm EX-99.2 6489
4 EX-99.3 d187488dex993.htm EX-99.3 5166
5 GRAPHIC g187488dsp5.jpg GRAPHIC 2622
6 GRAPHIC g187488dsp6.jpg GRAPHIC 2444
7 GRAPHIC g187488dsp6a.jpg GRAPHIC 2977
  Complete submission text file 0001193125-21-313125.txt   45650
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 211362621
SIC: 2834 Pharmaceutical Preparations